INHIBRX INC
France's Sanofi to buy US drugs project INBRX-101 for about $2.2 billionFrench healthcare company Sanofi has agreed to buy drug development project INBRX-101 from parent company Inhibrx Inc for $2.2 billion. INB...
- Load More
Stock Radar: Oberoi Realty breaks out of inverse head & shoulder pattern; time to buy?
A ghost particle hit Antarctica, and led scientists to a hidden galaxy 11 billion light-years away
Bengaluru techie, earning Rs 45 LPA, shocks Internet: ‘I don’t have anything left…’
US stocks today: US stocks end higher as Iran tensions ease; major tech-related shares jump
Espire Hospitality posts revenue of Rs 141 crore for FY26, PAT at Rs 8 crore
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service